Follow The Filings

Insider trades

Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.

4,793 companies covered Latest filing Oct 7 History loaded for 678 of 4,793

  • $2.1B bought by 554 insiders at 344 companies
  • $9.7B sold by 666 insiders outside a trading plan
  • $4.6B sold by 965 insiders under 10b5-1 plans
  • 10 companies where two or more insiders bought (30 days)

Biggest buys

Past month · by insider, all their filings added up

  1. LENLennar Corporation
    Berkshire Hathaway Inc.10% owner · +1 joint filer
    7,502,276 shares at $79.35 Sep 17–Oct 2 · 4 filings 3 superinvestors bought in Q2
    $595M
  2. RSGRepublic Services, Inc.
    Cascade Investment, L.l.c.10% owner · +1 joint filer
    2,036,917 shares at $222.69 Sep 3–11 · 3 filings +1.8% to stake
    $454M
  3. GPIGroup 1 Automotive, Inc.
    Conifer Management, L.L.C.10% owner
    689,930 shares at $259.42 Sep 3–30 · 5 filings +56% to stake 2 superinvestors bought in Q2
    $179M
  4. CRBGCorebridge Financial Inc.
    Life Insurance Co Nippon10% owner
    4,614,523 shares at $34.29 Sep 9–Oct 2 · 18 filings +3.8% to stake 2 superinvestors bought in Q2
    $158M
  5. KODKodiak Sciences Inc
    Baker Bros. Advisors LPDirector · +5 joint filers
    1,941,755 shares at $80.85 Sep 28–29 · 3 filings +11% to stake 1 superinvestor sold in Q2
    $157M
  6. UUUUniversal Safety Products, Inc.
    Milton C Ault IIIDirector
    34,934 shares at $2,647.81 Sep 1–30 · 6 filings
    $92.5M
  7. GMEGameStop Corporation
    Ryan CohenCEO
    3,300,680 shares at $22.55 Sep 10–Oct 2 · 4 filings +8.6% to stake
    $74.4M
  8. FTKFlotek Industries, Inc.
    Matthew WilksDirector
    1,319,493 shares at $26.01 Sep 11 +836% to stake 2 superinvestors bought in Q2
    $34.3M
  9. PAMTPamt Corp.
    Matthew T MorounDirector
    3,268,000 shares at $9.56 Sep 3 +26% to stake
    $31.2M
  10. GRABGrab Holdings Limited
    Anthony Ping Yeow TanCEO
    10.4M shares at $2.89 Sep 21 +2415% to stake
    $29.9M

Biggest sales

Past month · by insider, all their filings added up · planned sales marked

  1. FANGDiamondback Energy, Inc.
    SGF FANG Holdings, LP10% owner · +1 joint filer
    18.2M shares at $205.26 Sep 16 · 2 filings 22% of stake
    $3.7B
  2. MDLNMedline Inc.
    GIC Private Ltd10% owner · +2 joint filers
    20.7M shares at $34.90 Oct 2–6
    $722M
  3. NVDANvidia Corporation Com
    Mark A StevensDirector
    2,388,239 shares at $224.34 Sep 3–18 · 2 filings 71% of stake
    $536M
  4. INGMIngram Micro Holding Corporation
    Platinum Equity, LLC10% owner · +9 joint filers
    15.1M shares at $27.19 Sep 10–15 · 2 filings 8.5% of stake
    $410M
  5. IHTInnSuites Hospitality Trust
    Marc E BergEVP & Secretary/Treasurer
    16,000 shares at $22,593.60 Sep 17 33% of stake Planned sale (10b5-1)
    $361M
  6. DELLDell Technologies Inc.
    Silver Lake Partners IV, L.P.Director · +4 joint filers
    660,702 shares at $538.93 Sep 3–21 · 12 filings
    $356M
  7. DELLDell Technologies Inc.
    Sl Spv-2, L.P.Director · +4 joint filers
    536,699 shares at $539.22 Sep 3–17 · 10 filings 82% of stake
    $289M
  8. AVGOBroadcom Inc.
    Henry SamueliDirector
    702,190 shares at $356.04 Sep 23 1.9% of stake Planned sale (10b5-1)
    $250M
  9. CHYMChime Financial, Inc.
    DST Global Advisors Ltd10% owner · +9 joint filers
    6,966,664 shares at $33.95 Sep 9–14 · 6 filings 95% of stake
    $237M
  10. UMCUnited Microelectronics Corporation
    Chitung LiuCFO
    1,600,000 shares at $143.00 Sep 16–17 38% of stake
    $229M

Cluster buying

Companies where two or more insiders bought on the open market in the last 30 days · most buyers first

  1. TSMTaiwan Semiconductor Mfg Ltd 21 insiders · $86K

    Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more

    Latest buy Sep 7 21 executives 20 superinvestors sold in Q2
  2. SPGSimon Property Group, Inc. 11 insiders · $461K

    Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more

    Latest buy Sep 30
  3. SBLKStar Bulk Carriers Corp. 7 insiders · $4.8M

    Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more

    Latest buy Sep 15 3 executives 1 superinvestor bought in Q2
  4. FULH. B. Fuller Company 7 insiders · $621K

    Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more

    Latest buy Sep 30 1 superinvestor bought in Q2
  5. RWTRedwood Trust, Inc. 6 insiders · $969K

    Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more

    Latest buy Sep 21 5 executives
  6. MPBMid Penn Bancorp 6 insiders · $32K

    Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more

    Latest buy Sep 30 1 executive
  7. GMEGameStop Corporation 5 insiders · $76.4M

    Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more

    Latest buy Oct 2 1 executive
  8. PMTSCPI Card Group Inc. 5 insiders · $12M

    Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more

    Latest buy Sep 14 1 executive
  9. XBPXBP Global Holdings, Inc. 5 insiders · $2.4M

    Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more

    Latest buy Sep 15 2 executives
  10. BWFGBankwell Financial Group, Inc. 5 insiders · $435K

    Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more

    Latest buy Sep 8

All insider trades

Newest filings first · one row per filing · every open-market buy and sale

  1. Carolyn Schwab-Pomerantz Director
    SCHWThe Charles Schwab Corp.
    Sale
    $2M 18,561 shares at $107.70 1.4% of stake
    Traded Aug 5 Filed Aug 7
  2. Guillaume Marie Jean Rutten Director
    AMKRAmkor Technology, Inc.
    Sale
    $2.7M 50,000 shares at $54.93 9.8% of stake
    Traded Aug 5–6 Filed Aug 7
  3. David C Habiger Director
    BSXBoston Scientific Corp.
    Buy
    $100K 2,100 shares at $47.59 +14% to stake
    Traded Aug 5 Filed Aug 7
  4. Marc L Andreessen Director
    METAMeta Platforms, Inc., Class A
    Sale
    $251K 426 shares at $588.98 100% of stake
    Traded Aug 4 Filed Aug 6
  5. Richard N Nottenburg Director
    APLDApplied Digital Corporation
    Sale
    $2.3M 75,000 shares at $31.15 36% of stake
    Traded Aug 4 Filed Aug 6
  6. Rita J. Heise Director
    FASTFastenal Company
    Sale
    $1.8M 34,964 shares at $50.05 64% of stake
    Traded Aug 5 Filed Aug 6
  7. Phillip Et Al Frost MD Director
    COCPCocrystal Pharma, Inc.
    Buy
    $9,816 10,000 shares at $0.9800 +0.5% to stake
    Traded Aug 5 Filed Aug 6
  8. Keith A. Meister Director
    ILMNIllumina, Inc.
    Sale
    $148M 741,127 shares at $199.91 26% of stake
    Traded Aug 4–5 Filed Aug 6
  9. Michael P Huerta Director
    DALDelta Air Lines Inc.
    Sale
    $292K 3,100 shares at $94.12 8.7% of stake
    Traded Aug 5 Filed Aug 6
  10. Carolyn Schwab-Pomerantz Director
    SCHWThe Charles Schwab Corp.
    Sale
    $2.4M 22,640 shares at $106.36 1.6% of stake
    Traded Aug 4 Filed Aug 5
  11. John B Hess Director
    CVXChevron Corporation
    Sale
    $157M 810,665 shares at $194.12
    Traded Aug 3 Filed Aug 5
  12. David G Dewalt Director
    DALDelta Air Lines Inc.
    Sale
    $2.9M 31,756 shares at $90.85 59% of stake
    Traded Aug 3 Filed Aug 5
  13. Richard A Young Director
    CAMPCAMP4 Therapeutics Corporation
    Buy
    $27K 16,378 shares at $1.65 +9.6% to stake
    Traded Aug 3 Filed Aug 5
  14. David C Habiger Director
    BSXBoston Scientific Corp.
    Buy
    $57K 1,182 shares at $48.13 +8.5% to stake
    Traded Aug 3–4 Filed Aug 5
  15. Phillip Et Al Frost MD Director
    COCPCocrystal Pharma, Inc.
    Buy
    $71K 75,000 shares at $0.9400 +3.9% to stake
    Traded Aug 3 Filed Aug 5
  16. Ronald E Blaylock Director
    PFEPfizer Inc.
    Buy
    $999K 39,231 shares at $25.46 +142% to stake
    Traded Aug 5 Filed Aug 5
  17. Mortimer J Buckley Director
    PFEPfizer Inc.
    Buy
    $960K 37,632 shares at $25.52 New stake
    Traded Aug 5 Filed Aug 5
  18. Howard T Slayen Director
    AEHRAehr Test Systems
    Sale
    $2.2M 20,000 shares at $108.30 12% of stake
    Traded Aug 4 Filed Aug 4
  19. Charles R. Schwab Chair
    SCHWThe Charles Schwab Corp.
    Sale
    $15.1M 142,900 shares at $105.70 0.3% of stake
    Traded Aug 3–4 Filed Aug 4
  20. John Ronald Jeffrey Jr. Director
    AGXArgan, Inc.
    Sale
    $3.3M 5,716 shares at $579.64 69% of stake
    Traded Jul 31 Filed Aug 4
  21. Luis A Gonzalez Director · +1 joint filer
    AVOMission Produce, Inc.
    Sale
    $2.7M 201,176 shares at $13.46 2.8% of stake
    Traded Sep 18–20 Filed Aug 4
  22. Christopher B Paisley Director
    EQIXEquinix, Inc.
    Sale
    $4.1M 4,000 shares at $1,019.28 22% of stake
    Traded Aug 3 Filed Aug 3
  23. Edward J Ludwig Director
    BSXBoston Scientific Corp.
    Buy
    $227K 5,000 shares at $45.48 +20% to stake
    Traded Jul 31 Filed Aug 3
  24. Richard Mora Director
    ENPHEnphase Energy, Inc.
    Sale
    $74K 2,000 shares at $36.76 14% of stake
    Traded Jul 30 Filed Jul 31
  25. Charles R. Schwab Chair
    SCHWThe Charles Schwab Corp.
    Sale
    $15.2M 143,450 shares at $105.74 0.5% of stake
    Traded Jul 28–29 Filed Jul 30
  26. Carolyn Schwab-Pomerantz Director
    SCHWThe Charles Schwab Corp.
    Sale
    $2.4M 22,650 shares at $105.71 1.6% of stake
    Traded Jul 28 Filed Jul 30
  27. Fernando Adrian Elsztain Director
    CRESYCresud S.A.C.I.F. y A.
    Sale
    $45K 39,385 shares at $1.15 5.7% of stake
    Traded Jul 6–22 Filed Jul 30
  28. Fernando Adrian Elsztain Director
    CRESYCresud S.A.C.I.F. y A.
    Sale
    $124K 101,000 shares at $1.23 13% of stake
    Traded Apr 21–Jun 11 Filed Jul 30
  29. Walter W Bettinger Chair
    SCHWThe Charles Schwab Corp.
    Sale
    $29.8M 285,896 shares at $104.14 35% of stake
    Traded Jul 27–28 Filed Jul 29
  30. Mary L Schapiro Director
    MSMorgan Stanley
    Sale
    $212K 1,000 shares at $212.06 2.4% of stake
    Traded Jul 28 Filed Jul 29
  31. Michael J Ancius Director
    FASTFastenal Company
    Sale
    $147K 3,000 shares at $49.00 4.9% of stake
    Traded Jul 28 Filed Jul 29
  32. Charles R. Schwab Chair
    SCHWThe Charles Schwab Corp.
    Sale
    $4.6M 45,500 shares at $101.72 0.1% of stake
    Traded Jul 24 Filed Jul 28
  33. Tracy A Atkinson Director
    RTXRtx Corporation
    Sale
    $500K 2,295 shares at $218.05 56% of stake
    Traded Jul 27 Filed Jul 28
  34. Jarrod M Patten Director
    MSTRStrategy Inc.
    Sale
    $372K 3,900 shares at $95.47 12% of stake
    Traded Jul 24–27 Filed Jul 28
  35. Herbert Hughes Director
    BYRNByrna Technologies, Inc.
    Buy
    $15K 4,000 shares at $3.80 +2.4% to stake
    Traded Jul 27–28 Filed Jul 28
  36. Chris Lavern Reed Director
    BYRNByrna Technologies, Inc.
    Buy
    $30K 8,150 shares at $3.63 +15% to stake
    Traded Jul 24 Filed Jul 28
  37. Jarrod M Patten Director
    MSTRStrategy Inc.
    Sale
    $125K 1,250 shares at $100.00 4.2% of stake
    Traded Jul 22 Filed Jul 23
  38. Ronald W Tysoe Director
    CTASCintas Corporation
    Sale
    $872K 4,363 shares at $199.90 16% of stake
    Traded Jul 22 Filed Jul 23
  39. Herbert Hughes Director
    BYRNByrna Technologies, Inc.
    Buy
    $74K 21,681 shares at $3.42
    Traded Jul 22–23 Filed Jul 23
  40. Tj Kennedy Chair
    BYRNByrna Technologies, Inc.
    Buy
    $102K 29,000 shares at $3.53 New stake
    Traded Jul 22 Filed Jul 23
  41. Ken Herrmann Director
    AKTSAktis Oncology, Inc.
    Sale
    $119K 4,856 shares at $24.56 100% of stake
    Traded Jul 20 Filed Jul 21
  42. Melanie W. Barstad Director
    CTASCintas Corporation
    Sale
    $1.9M 9,142 shares at $202.94 26% of stake
    Traded Jul 16 Filed Jul 20
  43. Lewis H Titterton Jr. Director
    ANIXAnixa Biosciences, Inc.
    Buy
    $42K 12,000 shares at $3.47 +1.2% to stake
    Traded Jul 20 Filed Jul 20
  44. Ken Herrmann Director
    AKTSAktis Oncology, Inc.
    Sale
    $77K 3,065 shares at $25.21 100% of stake
    Traded Jul 17 Filed Jul 20
  45. Ting Shu Director
    COE51Talk Online Education Group
    Buy
    — 7,471,500 shares +32% to stake
    Traded Mar 26 Filed Jul 20
  46. Ramiro G Peru Director
    ELVElevance Health Inc. Formerly
    Buy
    $366K 1,000 shares at $366.05 +10% to stake
    Traded Jul 17 Filed Jul 17
  47. Geoffrey Gates Scott Director
    AEHRAehr Test Systems
    Sale
    $1.6M 20,000 shares at $82.13 40% of stake
    Traded Jul 16 Filed Jul 17
  48. Jeffrey C. Tweedy Director
    ASOAcademy Sports and Outdoors, Inc.
    Sale
    $58K 1,200 shares at $48.00 10% of stake
    Traded Jul 16 Filed Jul 17
  49. Lewis H Titterton Jr. Director
    ANIXAnixa Biosciences, Inc.
    Buy
    $9,174 2,797 shares at $3.28 +0.3% to stake
    Traded Jul 15 Filed Jul 16
  50. Denis Oleary Director
    CRWDCrowdStrike Holdings, Inc.
    Sale
    $2.7M 14,500 shares at $187.87 29% of stake
    Traded Jul 13 Filed Jul 15

About this data

  • Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
  • Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
  • A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
  • Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
  • We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.